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Abstract: This study examined the impact of regular supervised exercise on body fat, 
assessed via anthropometry, and eating patterns of peripheral arterial disease patients with 
intermittent claudication (IC). Body fat, eating patterns and walking ability were assessed 
in 11 healthy adults (Control) and age- and mass-matched IC patients undertaking usual care 
(n = 10; IC-Con) or supervised exercise (12-months; n = 10; IC-Ex). At entry, all groups 
exhibited similar body fat and eating patterns. Maximal walking ability was greatest for 
Control participants and similar for IC-Ex and IC-Con patients. Supervised exercise resulted in 
significantly greater improvements in maximal walking ability (IC-Ex 148%–170% vs. IC-Con 
29%–52%) and smaller increases in body fat (IC-Ex −2.1%–1.4% vs. IC-Con 8.4%–10%).  
IC-Con patients exhibited significantly greater increases in body fat compared with Control  
at follow-up (8.4%–10% vs. −0.6%–1.4%). Eating patterns were similar for all groups at  
follow-up. The current study demonstrated that regular, supervised exercise significantly 
improved maximal walking ability and minimised increase in body fat amongst IC patients 
without changes in eating patterns. The study supports the use of supervised exercise to 
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minimize cardiovascular risk amongst IC patients. Further studies are needed to examine  
the additional value of other lifestyle interventions such as diet modification. 
Keywords: body fat; skinfold; walking; claudication; diet; training 
 
1. Introduction 
Peripheral arterial disease (PAD) is an occlusive vascular condition that affects up to 15% of  
the population [1–3] with patients typically exhibiting reduced peripheral blood flow, decreased 
walking ability and poor quality of life [4–6]. Initial treatment normally involves risk factor control 
including medications and lifestyle modification in line with international guidelines [7]. The key 
lifestyle changes include smoking cessation, a controlled diet and increased performance of regular 
exercise [7]. Such lifestyle modifications have been demonstrated to promote weight loss or weight 
maintenance in healthy adults [8] and are recommended for obese individuals [7]. Many studies have 
reported that regular supervised exercise improves walking ability for PAD patients [9–11]. Whether 
such exercise programs influence diet, eating patterns and body composition is less clear for this 
population. Studies examining the effect of exercise on energy intake and food selection have reported 
inconsistent results for animal and human studies [12]. 
Previous reports suggested that PAD patients did not consume a diet in line with current 
recommendations [13]. It was reported that PAD patients ate high amounts of saturated fat, cholesterol 
and sodium, and low levels of fibre and folate [14]. A large cross-sectional analysis reported that high 
intake of vitamins A, C and B6, fibre, folate and omega-3 fatty acids was associated with lower 
prevalence of PAD within the USA population [15]. Consumption of a Mediterranean diet was also 
associated with a lower prevalence of PAD [16]. In contrast, another study suggested there was no 
relationship between PAD prevalence and diet when corrected for energy intake and physical activity 
levels [17]. A recent review suggested that behavioural weight management programs incorporating 
both diet and physical activity were optimal to reduce weight in overweight or obese adults [18]. 
Only one previous study has examined the effect of a combined dietary and exercise intervention  
for PAD patients to our knowledge [19]. These authors evaluated a lifestyle program, including dietary 
recommendations, moderate exercise and a smoking cessation intervention, in 13 PAD patients over  
15 months. The program resulted in a reduction in the number of patients smoking >1 packet per day 
(54.2% down to 7.7%), an increase in physical activity (number of patients walking >1 km from 13% up 
to 77%), and a reduction in caloric intake (10%), saturated fat (10%) and cholesterol (10%). The 
authors concluded that a lifestyle educational program focussing on diet, exercise and smoking cessation 
improved the risk factor profile of PAD patients. The program did not however have any effect on 
walking ability. 
The aim of the current study was to examine the impact of a regular supervised exercise program on 
body fat and eating patterns of PAD patients with intermittent claudication (IC). It was hypothesised that 
regular exercise would significantly reduce body fat and alter eating patterns [20] in patients with IC. 
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2. Results and Discussion 
Twenty patients with IC and 11 age- and mass-matched, healthy adults (Control) volunteered for 
this study and their characteristics are shown in Table 1. All groups were similar in age, height, mass, 
body mass index (BMI), girths, skinfolds (except mid-axilla) and body fat (%) at entry (Table 1). 
Walking ability was similar for each group of IC patients at entry and significantly lower than that for 
healthy controls (Table 1). Eating patterns were similar for all groups at entry except for weekly beer 
consumption. Weekly beer consumption was significantly greater for patients with IC undertaking usual 
care (IC-Con) compared with healthy controls (Q13a, Table 2). 
Table 1. Entry characteristics including anthropometric measures, body fat and walking ability 
amongst healthy adults (Control) and aged-matched patients with intermittent claudication 
undertaking usual care (IC-Con) or regular supervised exercise training (IC-Ex). 
Variable Control (n = 11) IC-Con (n = 10) IC-Ex (n = 10)
Age (years) 68.1 ± 6.8 66.5 ± 6.9 71.3 ± 8.5 
Height (cm) 167.8 ± 8.2 165.1 ± 9.0 165.7 ± 8.9 
Mass (kg) 70.7 ± 8.4 74.3 ± 19.9 80.7 ± 15.3 
BMI (kg/m2) 25.2 ± 3.2 27.0 ± 5.6 29.2 ± 4.1 
Waist Girth (cm) 85.5 ± 9.3 92.1 ± 16.0 96.1 ± 11.5 
Hip Girth (cm) 98.3 ± 7.3 101.3 ± 12.3 108.7 ± 9.5 
Waist:Hip ratio 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 
Skinfold (mm) 
Triceps 18.3 ± 8.7 18.5 ± 6.6 23.3 ± 8.1 
Subscapular 16.8 ± 8.7 22.0 ± 7.7 26.8 ± 12.3 
Biceps 8.8 ± 5.7 9.8 ± 4.3 14.5 ± 9.0 
Iliac Crest 16.4 ± 9.5 18.6 ± 10.6 29.5 ± 19.9 
Supraspinale 13.4 ± 10.0 13.1 ± 9.0 28.4 ± 20.8 
Abdominal 27.4 ± 12.4 29.6 ± 13.1 44.5 ± 19.1 
Thigh 23.7 ± 11.1 22.6 ± 10.5 31.0 ± 17.1 
Calf 16.4 ± 9.7 12.7 ± 5.8 20.2 ± 13.7 
Mid-axilla 15.5 ± 7.2 18.3 ± 9.7 28.2 ± 12.8 *,† 
Body Fat (%) 
LifeSize [21] 33.8 ± 19.3 26.5 ± 7.5 36.3 ± 18.9 
Durnin & Womersley [22] 25.9 ± 10.6 29.2 ± 7.2 30.6 ± 8.3 
Katch & McArdle [23] 25.8 ± 13.3 29.5 ± 13.7 25.9 ± 19.6 
Sloan [24] 19.5 ± 8.8 24.6 ± 7.2 26.9 ± 13.1 
Wilmore & Behnke [25] 24.4 ± 8.4 24.9 ± 7.3 26.3 ± 11.5 
Thorland et al. [26] 22.9 ± 10.7 26.5 ± 10.1 29.1 ± 14.1 
Withers et al. [27] 22.9 ± 10.4 23.0 ± 6.3 27.8 ± 10.7 
Walking Ability 
Pain Free Walking Distance (m) No pain at all 103 ± 88 115 ± 48 
Maximal Walking Distance (m) 977 ± 402 251 ± 163 * 285 ± 135 * 
Values are mean ± SD; BMI—Body mass index; * p < 0.05 vs. Control † p < 0.05 vs. IC-Con. 
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Table 2. Eating patterns amongst healthy adults (Control) and aged-matched patients with 
intermittent claudication undertaking usual care (IC-Con) or supervised exercise (IC-Ex) 
prior to and at 3- and 12-months of the study. 
Group 0-Month 3-Months 12-Months 
Q1 
Control 4 (3, 4.5) 4 (3.5, 4.5) 4 (2.5, 4) 
IC-Con 4 (3, 4) 4 (3, 4) 4 (3.25, 4) 
IC-Ex 4 (3, 4.75) 4 (3.25, 5) 4 (3.25, 4) 
Q2 
Control 3 (2.5, 4) 4 (2.5, 4) 3 (2, 4) 
IC-Con 4 (3.25, 4.75) 4 (3.25, 4) 4 (4, 4) 
IC-Ex 4 (4, 5) 4 (3.25, 4) 4 (4, 4) 
Q3 
Control 4 (3, 4.5) 4 (4, 4.5) 4 (3.5, 4) 
IC-Con 4 (3.25, 5) 4 (3.25, 5) 4 (3.25, 5) 
IC-Ex 4 (2.25, 4) 3 (2, 4) 4 (3.25, 4) 
Q4 
Control 4 (4, 4.5) 4 (4, 4) 4 (4, 4) 
IC-Con 4 (4, 4) 4 (4, 4) 5 (4, 5) 
IC-Ex 4 (4, 5) 4 (4, 4) 4 (4, 4.75) 
Q5 
Control 5 (3.5, 5) 4 (4, 5) 5 (4, 5) 
IC-Con 3 (2.25, 4) 3 (3, 4) 3 (2, 3) * 
IC-Ex 4 (2.5, 4.75) 4 (3, 5) 4 (3, 4) *,† 
Q6 
Control 3 (3, 3) 3 (2, 3) 3 (2, 3) 
IC-Con 2 (2, 2.75) 2 (2, 3) 2 (2, 3) 
IC-Ex 2 (2, 2.75) 2.5 (2, 3) 2 (2, 2.75) 
Q7 
Control 3 (2, 3.5) 3 (2, 3) 3 (2, 4) 
IC-Con 2 (2, 2) 2 (2, 2.75) 2.5 (2, 3) 
IC-Ex 2 (2, 2.75) 3 (2, 3) 2 (2, 3.75) 
Q8 
Control 4 (3, 4) 4 (3.5, 4) 4 (3.5, 4) 
IC-Con 4 (3, 4) 3 (3, 4) 4 (3, 4) 
IC-Ex 3.5 (3, 4) 3 (3, 4) 3.5 (3, 4) 
Q9 
Control 2 (2, 2) 2 (2, 2) 2 (2, 2) 
IC-Con 2 (2, 2) 2 (2, 2) 2 (2, 2) 
IC-Ex 2 (2, 2) 2 (2, 2) 2 (2, 2) 
Q10 
Control 3 (2.5, 3) 3 (2.5, 3) 3 (3, 3) 
IC-Con 3 (2, 3) 3 (2.25, 3.75) 3 (2, 3.75) 
IC-Ex 2.5 (2, 3) 3 (2, 3) 2.5 (2, 3.75) 
Int. J. Mol. Sci. 2015, 16 11343 
 
 
Table 2. Cont. 
Group 0-Month 3-Months 12-Months 
Q11 
Control 2 (1, 3.5) 1 (1, 4.5) 1 (1, 3.5) 
IC-Con 2 (1, 3.75) 1.5 (1, 4.75) 2.5 (1, 4.75) 
IC-Ex 1 (1, 3.75) 1.8 (1, 4.75) 1 (1, 2) 
Q12 
Control 1 (1, 1) 1 (1, 1) 1 (1, 1) 
IC-Con 1 (1, 1) 1 (1, 1.75) 1 (1, 1) 
IC-Ex 1 (1, 1) 1 (1, 1.5) 1 (1, 1) 
Q13a 
Control 1 (1, 1) 1 (1, 1) 1 (1, 1) 
IC-Con 1 (1, 2) * 1 (1, 2) 1 (1, 1) 
IC-Ex 1 (1, 1) 1 (1, 1.3) 1 (1, 1) 
Q13b 
Control 1 (1, 1.5) 1 (1, 2) 1 (1, 2) 
IC-Con 1 (1, 1) 1 (1, 1) 1 (1, 1) 
IC-Ex 1 (1, 1) 1 (1, 1) 1 (1, 1) 
Q13c 
Control 1 (1, 1) 1 (1, 1) 1 (1, 1) 
IC-Con 1 (1, 1) 1 (1, 1) 1 (1, 1) 
IC-Ex 1 (1, 1) 1 (1, 1) 1 (1, 1) 
Values are median (interquartile range) responses to eating patterns questionnaire (see Appendix A);  
* p < 0.05 vs. Control † p < 0.05 vs. IC-Con. 
2.1. Impact of Regular Supervised Exercise 
Regular supervised exercise resulted in significantly greater improvements in walking ability for patients 
with IC (IC-Ex) compared to both control groups (IC-Con and Control) at 3- and 12-months (Table 3). 
Improvements in walking ability were similar for Control and IC-Con at 3- and 12-months (Table 3). 
2.1.1. Body Fat 
Significantly greater reductions in body mass, and supraspinale and mid-axilla skinfolds were noted 
for patients undertaking supervised exercise (IC-Ex) compared to the usual care (IC-Con) group  
(Table 3). The reductions in skinfolds for IC-Ex patients remained at 12-months (Table 3). Similarly, 
increases in body fat (%) were smaller for the IC-Ex compared to the IC-Con group at 3- (via LifeSize 
equation) and 12-months (via LifeSize and Withers et al. equations) and comparable to that of  
healthy controls (Table 3). In contrast, IC-Con patients exhibited significantly greater increases in 
body fat (%) compared with the Control adults at 3- (via LifeSize equation) and 12-months (via 
LifeSize and Withers et al. equations, Table 3). 
2.1.2. Eating Patterns 
Eating patterns were similar for all groups at 3- and 12-months of the study (Table 2). 
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Table 3. Absolute or relative (%) change in walking ability, anthropometric measures  
and body fat of healthy adults (Control) and age- matched patients with intermittent 
claudication undertaking 3 and 12 months of usual care (IC-Con) or regular supervised 
exercise training (IC-Ex). 
Variable Time Point Control (n = 11) IC-Con (n = 10) IC-Ex (n = 10) 
Walking Ability (%) 
Pain free walking distance 
3 months N/A 47.6 ± 66.4 166.4 ± 143.4 # 
12 months N/A 102.2 ± 160.8 242.1 ± 166.8 † 
Maximal walking distance 
3 months 30.5 ± 62.8 29.1 ± 67.0 148.1 ± 154.6 *,†
12 months 18.9 ± 47.9 52.3 ± 127.6 169.7 ± 166.0 *,†
Body mass (%) 
3 months −1.1 ± 2.6 0.7 ± 2.5 * −1.4 ± 2.0 † 
12 months −2.4 ± 4.1 −0.2 ± 2.9 0.9 ± 3.6 
Skinfold (%) 
Supraspinale 
3 months 2.1 ± 17.9 3.7 ± 10.3 −19.7 ± 21.4 *,† 
12 months 2.9 ± 27.0 16.6 ± 40.3 −26.0 ± 28.7 *,† 
Mid-axilla 
3 months −7.0 ± 25.3 6.1 ± 15.4 −17.3 ± 23.5 † 
12 months 3.9 ± 32.2 −3.2 ± 19.0 −23.6 ± 17.7 *,† 
Body Fat (Absolute) 
LifeSize [21] 
3 months −0.6 ± 1.9 10.0 ± 10.8 * 1.4 ± 8.8 # 
12 months −1.4 ± 2.1 8.4 ± 11.1 * −2.1 ± 9.9 # 
Withers et al. [27] 
3 months −0.6 ± 2.0 1.8 ± 3.3 −1.3 ± 4.1 
12 months −1.2 ± 1.8 0.8 ± 3.5 * −3.7 ± 5.4 † 
Values are mean ± SD; N/A not applicable; # p < 0.06 vs. IC-Con; † p < 0.05 vs. IC-Con; * p < 0.05 vs. Control. 
The current study demonstrated that regular, supervised exercise significantly increased maximal 
walking ability for IC patients as previously reported [11,28–30]. The main novel finding we reported 
was that supervised exercise was associated with less increase in body fat compared to usual care. 
Previous studies have documented significant improvements in walking ability with both short- [31] 
and long-term [10,32,33] training however, changes in body fat following exercise training have been 
rarely reported for PAD patients. We previously reported a strong association between obesity and the 
severity of IC and complications in PAD patients [34]. Others have also associated obesity with poorer 
walking ability [35], limited exercise performance [36] and reduced improvements in walking following 
supervised exercise [37] amongst PAD patients. In contrast to those previous reports, we recently 
reported that obesity was associated with increased survival amongst a group of approximately 1500 
patients with heterogeneous presentations of peripheral vascular disease [38]. This obesity paradox has 
been previously reported in patients with a range of significant medical conditions [39–41]. While 
these above reports appear contradictory, there may be some reasonable explanations. It is possible 
that amongst patients with milder types of PAD, such as those with IC suitable for exercise training, 
obesity is associated with a poorer prognosis. In patients with more severe types of arterial disease, 
such as those with critical limb ischemia, obesity may have different prognostic significance. For these 
patients, obesity may be a marker of less advanced disease, reduced frailty and greater robustness to 
withstand multiple hospital admission and events typically experienced by these individuals. 
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In the current study, we showed that supervised walking training resulted in reduced body fat 
accumulation for IC patients. The smaller body fat increase was independent of physical activity  
levels, additional to the supervised exercise program, that were unchanged during the 12 month study 
period [11]. Recently, Li and colleagues concluded in their review [20] that exercise training 
frequency, quantity and mode (aerobic exercise like walking) had an important influence on weight 
loss. The current results provide further support that aerobic exercise can assist with body fat 
modification. The reduced fat accumulation was primarily demonstrated within the torso. Several 
skinfold measurements at the supraspinale and mid-axilla regions were significantly reduced in patients 
randomized to supervised exercise. Skinfolds assessed at the iliac crest and abdomen were also reduced in 
patients receiving supervised exercise although the trend was not significantly different to the control 
group. Abdominal fat accumulation has been associated with poorer exercise performance [36] and 
increased complications [34,42]. Collectively, these results suggest that regular supervised exercise 
results in less accumulation of subcutaneous body fat which may contribute to better patient outcomes. 
A novel finding of the current study was the increase in body fat (via LifeSize and Withers et al. 
equations) over 3–12 months for patients undertaking usual care (IC-Con). Further, this change occurred 
with similar eating patterns to that of other IC patients and healthy, aged-matched adults. To our 
knowledge, no study of IC patients has reported this detrimental change in patient’s body fat and provides 
further support for the inclusion of exercise within the care plans for IC [7]. The previously reported 
associations between obesity and the severity, functional impairment and complications of PAD [34–37] 
highlight the importance of interventions to limit body fat in IC patients. The current results indicate 
the importance of supervised exercise for IC patients which is not routinely available. 
The body fat change for patients receiving supervised exercise occurred independently of eating 
patterns. Leone and colleagues [43] reported that training responses for PAD patients were similar 
regardless of the presence of risk factors such as smoking, hypertension, and obesity. The current 
results extend these findings to demonstrate the negligible impact of eating patterns on body fat changes 
during exercise interventions. Several epidemiological studies have reported greater PAD prevalence 
amongst individuals that consume greater amounts of saturated fat and reduced intake of some  
vitamins [44]. Very few of these analyses however have adjusted for exercise level amongst patients 
and therefore, it is not currently clear whether physical activity or exercise, nutrition or both are 
important in determining the prevalence and complications of PAD. 
Supervised exercise has demonstrated positive gains for patients with IC however whether this 
intervention should be combined with a nutritional program is not currently clear. Such lifestyle 
programs have reported benefits amongst a number of different populations such as healthy adults [18] 
and patients with metabolic syndrome [45]. Similar programs may also result in health benefits for 
PAD patients. Ramirez-Tortosa and colleagues [19] reported that PAD patients who undertook  
a combined diet and moderate exercise intervention over 15 months exhibited greater physical activity 
levels and better diet. Future studies are needed to identify the optimal design of exercise focused 
interventions and the advantage of combining these with a nutritional program. 
The current study has a number of limitations. Analysis was limited to a small sample of PAD 
patients as has been the case in most previous studies of supervised exercise [19]. Eating patterns were 
determined from a questionnaire alone rather than more detailed assessments including total caloric 
intake from food diaries or direct observations [15]. Finally, body fat was assessed from skinfold 
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measurements that required significant technical expertise and use of a number of body fat% equations 
of variable results. For example, the body fat% change at 3-months for IC-Con using the LifeSize 
equation was substantially greater than that for the Withers et al. equation (Table 3). Information 
concerning the LifeSize equation was not available due to proprietary restrictions but the 
methodological differences between body fat% equations may influence interpretations. Future studies 
using more advanced techniques such as DEXA, which can assess both fat and lean muscle mass, may 
better clarify the specific body composition responses to supervised exercise for PAD patients. 
3. Experimental Section 
3.1. Participants 
The design of this study has been previously reported [11,28–30]. Participants presenting with IC 
due to PAD were recruited based on the findings of history and physical examination following 
consultation with a vascular physician. Diagnosis of PAD was confirmed by ankle-brachial pressure 
(ABI) index <0.9 and lower limb artery stenoses or occlusions demonstrated on arterial duplex and/or 
computed tomography angiography. For comparison, a group of healthy, age- and mass-matched 
adults (Control, n = 11) that were free of PAD (ABI > 0.9) were recruited from the local community. 
All participants provided written informed consent to participate with the study approved by the 
Townsville Health Service District Institutional Ethics Committee (01/03, 16 January 2003) and James 
Cook University Human Research Ethics Committee (H1640, 28 August 2003). 
3.2. Assessments 
Participants arrived at the laboratory early in the morning after an overnight fast and completed  
a questionnaire inquiring about medical history, medications, comorbidities, smoking history [11]  
and eating patterns. Participants were asked about their eating of protein, dairy, desserts, fats, 
carbohydrates, fruit, vegetables, fast foods, salty foods, and alcohol consumption using a questionnaire 
(Wellsource Inc., Clackamas, OR, USA; Appendix A). 
Participant’s height was measured via stadiometer (Seca 220, Seca Scales, Hamburg, Germany) and 
body mass was assessed using scales (TANITA TBF 521, TANITA Corp., Arlington Heights, IL, 
USA). Body mass index (BMI) was calculated based upon height and mass and expressed in kg·m−2. 
Body fat was then determined from measurements using a restricted anthropometric profile as previously 
described [46,47]. The restricted anthropometric profile consisted of 9 skinfold measurements (i.e., 
triceps, biceps, subscapular, supra-iliac, abdominal, supra-spinale, mid-axilla, thigh and calf) (Table 1). 
All skinfold measurements were assessed in duplicate using calibrated calipers in accordance with 
international anthropometry guidelines [46]. Body fat percentage was calculated using a specialized 
computer program (i.e., LifeSize [21]; Human Kinetics, Champaign, IL, USA). Body fat (%) was also 
calculated using the previously employed equations of Durnin and Womersley [22], Katch and 
McArdle [23], Sloan [24], Wilmore and Behnke [25], Thorland et al. [26] and Withers et al. [27] 
within LifeSize [21,48]. Waist to hip ratio was assessed using a steel tape [46]. 
Exercise or walking capacity was assessed for each participant as previously described following 
familiarisation [11]. Briefly, participants completed an incremental exercise test on a motorized 
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treadmill (Trackmaster TMX55, Full Vision, Newton, KS, USA). The walking protocol was conducted 
at a constant speed of 3.2 km·h−1 with an incline of 0% for the first 2 min that was increased by 2% every  
2 min until volitional exhaustion [49] or a maximum of 25 min. Exercise capacity was assessed as  
walking distance that was pain free (PFWD) using a claudication pain scale [50] and maximal walking 
distance (MWD). 
3.3. Randomisation and Follow-Up 
Participants with PAD were randomly allocated using sealed envelopes to undertake supervised exercise 
(IC-Ex, n = 10) or usual care (IC-Con, n = 10) over 12 months. As previously reported [28], usual care 
consisted of standardised treatment in accordance with international guidelines [7]. Follow-up assessments 
were performed at 3- and 12-months. These time intervals were chosen since significant improvements in 
walking ability have been reported at 2–4 [31] and 12 months [10,11,32,33] previously. 
3.4. Exercise Training and Testing 
Patients randomized to receive supervised exercise completed three sessions of treadmill walking 
each week over 12 months at an intensity required to induce maximal claudication pain as previously 
described [11]. Initial walking sessions aimed to achieve 20 min of continuous walking with 
subsequent sessions increasing duration progressively to a maximum of 45 min of continuous walking. 
Workloads were monitored and amended as needed to ensure attainment of maximal claudication  
pain during each walking session. Compliance with this exercise program was good (>70%) over the 
12-month period as previously described [29]. 
3.5. Statistical Analysis 
Data are presented as mean ± SD or median and interquartile range after assessment of data 
normality and data type (nominal or categorical). As a result of the modest sample size and assessment 
of data normality, comparisons between groups at each time point (0-, 3- and 12-months) were 
conducted using Kruskal-Wallis and post-hoc Mann-Whitney U tests. Changes (e.g., 3- vs. 0-months) 
in body fat and walking capacity over time were also examined and expressed as absolute (e.g., body 
fat %) or relative differences (e.g., skinfold, walking distance). All comparisons were conducted using 
the Statistical Program for the Social Sciences (v20, IBM Corp., Armonk, NY, USA) and the level of 
significance was set at 0.05. 
4. Conclusions 
Regular, supervised exercise significantly improved maximal walking ability and minimised 
increases in body fat accumulation. Long-term supervised exercise programs have capacity to reduce 
cardiovascular risk amongst IC patients. Eating patterns were unchanged amongst IC patients involved 
in supervised exercise. Future studies are needed to examine the impact of combining dietary 
interventions with supervised exercise in PAD patients. 
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Appendix A: Eating Pattern Survey (Wellsource Inc, Clackamas, OR, USA) 
Mark the choices below that best describe your regular eating pattern. 
1. Meat/Protein foods 
Eat red meat (fat not trimmed), sausages, hamburgers or luncheon 
meats (devon, salamis) most days. 
 
1
Eat some red meat (not trimmed) or poultry with skin more than  
4 times per week, and fish occasionally. 
 
2
Eat mostly lean red meats, some skinless poultry, and some fish 
but choose steaks or dishes such as lasagne often when eating out. 
 
3
Eat moderate amounts of very lean meats and mostly skinless 
poultry and fish several times a week. 
 
4
Eat only small portions of very lean red meat or skinless poultry, 
have fish often and some legumes. 
 
5
2. Dairy Products/Eggs. Indicate the Kinds of Dairy Products You Usually Eat. 
High fat dairy products include butter, cream, sour cream (include light sour cream). Cheeses (include 
those marked fat-reduced but not those labelled 7% fat). Ice cream, full cream milk (except for small 
amounts added to tea or coffee), regular yoghurt (in amounts greater than 100 g). 
Low fat dairy products include skim or low fat milk, low fat yoghurt, cottage cheese. 
Nearly always eat the high fat products. 
 
1
Eat mostly the high fat products, some low fat. 
 
2
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Eat both about the same. 
 
3
Eat mainly low fat products and only small quantities of high fat. 
 
4
Eat only low fat products. 
 
5
3. Desserts/Snacks. Indicate the Kind of Desserts/Snacks You Usually Eat. 
High fat desserts/snacks include: ice-cream, cakes, pastries, pies or tarts, chocolate desserts, frozen 
yoghurt, mousse or cream caramel, home baked desserts which include butter or margarine, biscuits 
(sweet or savoury except low fat crispbread), chocolate bars of any kind, caramels. 
Low fat desserts/snacks include: fruit (fresh, dried or canned), fruit salads, low fat yoghurt (regular or 
frozen), low fat crispbread (rye or oat based), bread, whole-wheat breakfast biscuits, jelly. 
Eat at least one item from the high fat products most days. 
 
1
Eat at least one item from the high fat products at least every 
second day plus some low fat products. 
 
2
Eat both about the same.  
3
Eat mostly low fat products, high fat not more than once a week.  
4
Eat only low fat products or none at all. 
 
5
4. Cooking Fats/Food Preparation. Indicate the Way You Usually Prepare Foods or the Kinds of 
Cooked Foods You Choose When Eating Out. 
High fat methods: Deep-frying in oil or fat. Shallow frying in butter, margarine, lard, dripping or oil. 
Add extra butter, margarine, cream or oil to foods (e.g., pasta, vegetables, sauces). 
Low fat methods: Grilling, barbecuing, using only a little oil on a non-stick pan, roasting on a rack, 
microwaving without adding fat, making casseroles, and allowing the fat to settle on top before 
removing it. Using low fat dressings and sauces (e.g., based on tomato, wine, herbs, vegetables), 
substituting low fat yoghurt or evaporated skim milk for cream or butter. 
Food nearly always prepared the high fat way. 
 
1
Food mostly prepared the high fat way.  
2
Food prepared both ways about the same.  
3
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Food usually prepared the low fat way, do not have foods prepared 
the high fat way except for occasional restaurant meals. 
 
4
Food prepared only the low fat way. 
 
5
5. Breads, Grains and Cereals. Indicate the Kind of Breads and Grains You Usually Eat. 
High fibre products include wholemeal or wholegrain or increase fibre breads, rolls, muffins or fruit 
loaves, wholegrain breakfast cereals (e.g., whole-wheat breakfast biscuits, rolled oats, muesli, bran, 
wheat or oat cereals), wholemeal pasta, brown rice, millet, buckwheat, corn or rye products. 
Low fibre or refined products include white breads, cereals such as cornflakes or rice bubbles, white 
rice or pastas. 
1 2 3 4 5 
     
Always choose low 
fibre or refined products 
Eat mostly low fibre 
or refined products 
Eat both about 
the same 
Eat mainly high 
fibre products 
Always choose 
high fibre products 
6. Fruit. How Many Servings of High Fibre Fruit Products do You Eat? 
High fibre fruits are eaten with the skin where practical. Includes fresh, dried or canned. 
Low fibre fruit products include juices. 
1 2 3 4 
    
Almost never 1 serve a day 2–3 serves a day 3 or more serves a day 
7. Vegetables. How Many Servings of Vegetables do You Eat? Include Each Serve of Vegetables, 
Counting a Tossed Salad as One Serve. 
1 2 3 4 
    
Almost never 1 serve a day 2–3 serves a day 3 or more serves a day 
8. Fast Foods. How often do You Eat Foods such as Hamburgers, Pies, Chips, Fried Chicken, Hot 
Dogs, Sausage Rolls, Fried Asian Take-Aways? 
1 2 3 4 
    
Every day Several times a week 
Occasionally, not more than 
once every few weeks 
Seldom or never 
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9. Salty Foods. How often do You Eat Soy Sauce, Crisps or Other Savoury Snacks, Salted Crackers, 
Salted Peanuts, Salt Cured Foods such as Bacon, Salami, Ham, etc.? 
1 2 3 4 
    
Never Occasionally Most of the time Always 
10. Salt. How often do You Add Salt to Your Food? 
1 2 3 4 
    
Always Most of the time Occasionally Never 
11. During the Past Month, How Many Days did You Drink Alcoholic Beverages? 
1 2 3 4 5 
     
0–5 6–10 11–15 16–20 >20 
12. During the Past Month, How Many Times did You Have 5 or More Drinks per Occasion? 
1 2 3 4 5 
     
0–2 3–5 6–8 9–11 9–11 
13. On the Average, How Many Glasses of Beer, Wine or Spirits, do You Consume a Week? 
 1 2 3 4 5 
 0–5 6–10 11–15 16–20 >20 
(a) Beer      
(b) Wine      
(c) Spirits      
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